PD-L1 binding fibronectin type III domains
US11447539B2 · kind B2 · utility
0Cited by
50References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2020 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Feb 26, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/61
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
FN3 domains that specifically bind to PD-L1, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.